9 Meters Biopharma Net Income

9 Meters Biopharma (NMTRQ) currently reports a net income of $-50M as of March 2023. That compares with $-43M in the prior-year period — down 16.7% year over year. That is below the Technology sector average of $82T. Use the charts on this page to explore 9 Meters Biopharma's net income history and peer comparisons.

9 Meters Biopharma's net income decreased from $-43M to $-50M — a 16.7% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

9 Meters Biopharma's net income of $-50M is lower than the Technology sector average of $82T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

9 Meters Biopharma reported $-50M in net income as of March 2023. That compares with $-43M in the prior-year period — down 16.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-50M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is $82T. From there, open related valuation or income-statement pages for 9 Meters Biopharma, and consider following NMTRQ for alerts when major investors trade the stock.